Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Methodology
Signal backtests
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

REDMOND JOSEPH MICHAEL — PARALLAX HEALTH SCIENCES, INC. insider: 2 transactions · InsiderLens

/ / REDMOND JOSEPH MICHAEL

REDMOND JOSEPH MICHAEL

Director at PARALLAX HEALTH SCIENCES, INC. · on record since Jan 10, 2014
President at PARALLAX HEALTH SCIENCES, INC. · on record since Jan 18, 2017

Insider trading activity of REDMOND JOSEPH MICHAEL

Transactions on record: 2; since Jan 18, 2017

Open-market buys: 1

Open-market sells: 0

Companies traded: 1; last filing Jan 18, 2017

Figures computed from official regulatory filings — .

Companies where REDMOND JOSEPH MICHAEL has traded

PARALLAX HEALTH SCIENCES, INC.2 tx · Jan 18, 2017

Track record of REDMOND JOSEPH MICHAEL

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of REDMOND JOSEPH MICHAEL

Co-insiders of REDMOND JOSEPH MICHAEL

APPELL DAVIDPARALLAX HEALTH SCIENCES, INC.
ARENA PAUL RPARALLAX HEALTH SCIENCES, INC.
BRADLEY NATHANIEL TPARALLAX HEALTH SCIENCES, INC.
BUCCI CALLIPARALLAX HEALTH SCIENCES, INC.
Gorlach JornPARALLAX HEALTH SCIENCES, INC.
Ogden John LPARALLAX HEALTH SCIENCES, INC.
Withrow Edward W IIIPARALLAX HEALTH SCIENCES, INC.
WITHROW EDWARD W. JRPARALLAX HEALTH SCIENCES, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src	Details
PARALLAX HEALTH SCIENCES, INC.	Jan 18, 2017	Buy	600,000	0.00 USD	—	SEC
PARALLAX HEALTH SCIENCES, INC.	Jan 18, 2017	AwardD (derivative)	2,000,000	—	—	SEC